» Articles » PMID: 11394906

Glycogen Synthase Kinase 3beta is Tyrosine Phosphorylated by PYK2

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2001 Jun 8
PMID 11394906
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Glycogen synthase kinase 3beta (GSK3beta) is a Ser/Thr kinase that is involved in numerous cellular activities. GSK3beta is activated by tyrosine phosphorylation. However, very little is known about the tyrosine kinases that are responsible for phosphorylating GSK3beta. In this report, we investigated the ability of the calcium-dependent tyrosine kinase, proline-rich tyrosine kinase 2 (PYK2) to tyrosine phosphorylate GSK3beta. In transfected CHO cells, it was demonstrated that PYK2 tyrosine phosphorylates GSK3beta in situ. The two kinases also coimmunoprecipitated. Furthermore, GSK3beta was tyrosine phosphorylated in vitro by an active, wild type PYK2, but not by the inactive, kinase dead form of PYK2. Therefore, this study is the first to demonstrate that GSK3beta is a substrate of PYK2 both in vitro and in situ.

Citing Articles

Christchurch modulates β-catenin/Wnt signaling in iPS cell-derived cerebral organoids from Alzheimer's cases.

Perez-Corredor P, Vanderleest T, Vacano G, Sanchez J, Villalba-Moreno N, Marino C Front Mol Neurosci. 2024; 17:1373568.

PMID: 38571814 PMC: 10987717. DOI: 10.3389/fnmol.2024.1373568.


Reprogramming of cardiac phosphoproteome, proteome, and transcriptome confers resilience to chronic adenylyl cyclase-driven stress.

Qu J, Chakir K, Tarasov K, Riordon D, Perino M, Silvester A Elife. 2024; 12.

PMID: 38251682 PMC: 10945681. DOI: 10.7554/eLife.88732.


EGCG inhibits the inflammation and senescence inducing properties of MDA-MB-231 triple-negative breast cancer (TNBC) cells-derived extracellular vesicles in human adipose-derived mesenchymal stem cells.

Gonzalez Suarez N, Fernandez-Marrero Y, Hebert M, Roy M, Boudreau L, Annabi B Cancer Cell Int. 2023; 23(1):240.

PMID: 37833751 PMC: 10576371. DOI: 10.1186/s12935-023-03087-2.


GSK-3 at the heart of cardiometabolic diseases: Isoform-specific targeting is critical to therapeutic benefit.

Umbarkar P, Ruiz Ramirez S, Toro Cora A, Tousif S, Lal H Biochim Biophys Acta Mol Basis Dis. 2023; 1869(6):166724.

PMID: 37094727 PMC: 10247467. DOI: 10.1016/j.bbadis.2023.166724.


Discovery of GSK3β Inhibitors through In Silico Prediction-and-Experiment Cycling Strategy, and Biological Evaluation.

Lee Y, Yoon S, Hong H, Kim H, Jung D, Moon B Molecules. 2022; 27(12).

PMID: 35744952 PMC: 9230645. DOI: 10.3390/molecules27123825.